131 related articles for article (PubMed ID: 36073612)
1. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
[TBL] [Abstract][Full Text] [Related]
2. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
[TBL] [Abstract][Full Text] [Related]
3. Association Between Idiopathic Thrombocytopenic Purpura and Hemorrhagic and Nonhemorrhagic Stroke.
Guntu R; Patel A; Movahed MR; Hashemzadeh M; Hashemzadeh M
Crit Pathw Cardiol; 2024 Mar; 23(1):26-29. PubMed ID: 37625190
[TBL] [Abstract][Full Text] [Related]
4. The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study.
Chandan JS; Thomas T; Lee S; Marshall T; Willis B; Nirantharakumar K; Gill P
J Thromb Haemost; 2018 Mar; 16(3):474-480. PubMed ID: 29297977
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study.
Ekstrand C; Bahmanyar S; Cherif H; Kieler H; Linder M
Cancer Epidemiol; 2020 Dec; 69():101806. PubMed ID: 32947155
[TBL] [Abstract][Full Text] [Related]
6. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
7. Newly Diagnosed Leptospirosis and Subsequent Hemorrhagic Stroke: A Nationwide Population-Based Cohort Study.
Li KY; Chou MC; Wei JC; Lin MC; Hung YM; Chang R
Stroke; 2021 Mar; 52(3):913-921. PubMed ID: 33494640
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and characteristics of ischemic stroke in patients with immune thrombocytopenia: A retrospective cohort study.
Rong X; Jiang L; Qu M; Yang S; Wang K; Jiang L
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106693. PubMed ID: 36054971
[TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke/transient ischemic attack in adults with primary immune thrombocytopenia: a meta-analysis.
Pan L; Leng H; Huang Y; Xia N; Jin L; Zhang HT
Neurol Sci; 2021 May; 42(5):2013-2020. PubMed ID: 33006722
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
11. Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan.
Koseki M; Sheu MJ; Tsai KT; Ho CH; Liu HH; Lin HJ; Lin CL; Huang CC
BMC Gastroenterol; 2023 Feb; 23(1):36. PubMed ID: 36755235
[TBL] [Abstract][Full Text] [Related]
12. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
[TBL] [Abstract][Full Text] [Related]
13. Incidence of immune thrombocytopenia in Taiwan: a nationwide population-based study.
Hung GY; Lee CY; Yen HJ; Lin LY; Horng JL
Transfusion; 2018 Nov; 58(11):2712-2719. PubMed ID: 30311951
[TBL] [Abstract][Full Text] [Related]
14. Nonapnea sleep disorders are associated with subsequent ischemic stroke risk: a nationwide, population-based, retrospective cohort study.
Huang WS; Tsai CH; Lin CL; Sung FC; Chang YJ; Kao CH
Sleep Med; 2013 Dec; 14(12):1341-7. PubMed ID: 24211072
[TBL] [Abstract][Full Text] [Related]
15. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
Li S; Molony JT; Cetin K; Wasser JS; Altomare I
Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities in patients with persistent or chronic immune thrombocytopenia.
Enger C; Bennett D; Forssen U; Fogarty PF; McAfee AT
Int J Hematol; 2010 Sep; 92(2):289-95. PubMed ID: 20652840
[TBL] [Abstract][Full Text] [Related]
17. Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics.
Park HK; Lee SH
Neurol Sci; 2014 Nov; 35(11):1801-6. PubMed ID: 24880747
[TBL] [Abstract][Full Text] [Related]
18. Risk of stroke with antivenom usage after venomous snakebite in Taiwan: a population-based cohort study.
Hung WH; Sung J; Chen WY; Chiu LT; Yip HT; Wei JC; Hung YM; Chang R
QJM; 2022 Sep; 115(9):587-595. PubMed ID: 34613415
[TBL] [Abstract][Full Text] [Related]
19. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.
Frederiksen H; Maegbaek ML; Nørgaard M
Br J Haematol; 2014 Jul; 166(2):260-7. PubMed ID: 24690142
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors for Immune Thrombocytopenic Purpura Remission after Laparoscopic Splenectomy: A Cohort Study.
Kwiatkowska A; Radkowiak D; Wysocki M; Torbicz G; Gajewska N; Lasek A; Kulawik J; Budzyński A; Pędziwiatr M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31003557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
